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A small but growing number of people are finding interesting parallels between ecosystems as 
studied by ecologists (think of a Savanna or the Amazon rain forest or a Coral reef) and tumours1-3. 
The idea of viewing cancer from an ecological perspective has many implications but fundamentally, it 
means that we should not see cancer just as a group of mutated cells. A more useful definition of 
cancer is to consider it a disruption in the complex balance of many interacting cellular and 
microenvironmental elements in a specific organ. This  perspective means that organs undergoing 
carcinogenesis should be seen as sophisticated ecosystems in homeostasis  that cancer cells can 
disrupt. It also makes cancer seem even more complex but may ultimately provides isights that make 
it more treatable. Here we discuss how ecological principles can be used to better understand cancer 
progression and treatment, using several mathematical and computational models to illustrate our 
argument.
1. Cancer and ecosystems 
One of the primary aims of mathematical modelling is to make the system being studied more 
understandable. This often means defining the system as simply as possible, and not making it more 
complex than reality. Einstein is  known to have said that everything should be made as simple as 
possible, but not simpler4. It turns  out that complexity has  its place and, as  convenient as it would be 
for cancer biologists to study tumour cells in isolation, that makes as much sense as trying to 
understand frogs without considering that they tend to live near swamps and feast on insects. A frog’s 
sticky tongue makes much more sense when you consider how useful is it when trying to catch flies. 
Similarly, it makes sense that a cancer cell that is  close to a blood vessel and is  capable of producing 
Vascular Endothelial Growth Factors (VEGF) would benefit from co-opting endothelial cells  to grow its 
very own vasculature and obtain more nutrients and oxygen. This  dialogue between tumour cells and 
their environment is critical to understanding how an ecological view of cancer may be beneficial. The 
standard gene centric view states that cancer is only a product of mutation but since the importance 
of a mutation only makes sense when we understand the context. The context in which genes 
operate is ultimately the ecosystem. An ecosystem is made of individuals (plants, animals, bacteria, 
independent cells,...) and the physical environment they inhabit (water, soil, oxygen, food, etc). 
Survival and proliferation, the only things  that matter at the evolutionary level, depend on how well a 
cell competes for the existing resources and cooperates  with other cells  to produce new ones. Even a 
simplified ecosystem should showcase the interdependence of species and how important the 
interactions between them are. In many ecosystems, the species and the way they interact do not 
change significantly over time. Occasionally, changes in the environment or a new species invading 
the ecosystem can disrupt the existing homeostasis. From the cancer ecology perspective, 
tumourigenesis is  the process by which the homeostasis that characterises a healthy tissue is 
disrupted either via changes in the tissue microenvironment, or by an invading species (some 
bacteria and viruses are known to be able to lead to tumourigenesis), or a local invasion (a resident 
species producing a brand new one as a result of mutations).
The local environment is thus an important factor, not only in traditional ecosystems but also in 
cancer. This idea dates back to the late 19th century with Paget's well known seed-soil hypothesis 5 
which suggests that for successful metastases, the soil (the site of a metastasis) is as important as 
the seed (the metastatic cells). It is now beginning to be widely 
accepted that cancer is not just a genetic disease but one in which 
evolution plays a crucial role1,3. This  means that tumour cells evolve, 
adapt to and change the environment in which they live. The ones 
that fail to do so will ultimately become extinct. The ones that do, will 
have a chance to invade and metastasise. The capacity of a tumour 
cell to adapt to a new environment will thus be determined by 
environment and the cellular species  from the original site, to which it 
has already painstakingly adapted.
Adaptation is the key process  for any system subject to Darwinian 
evolution, and cancer is no exception 6. Because its  role in Cancer is 
only now beginning to be explored, the full implications have yet to 
impact the cancer research community at large. Tumour cell 
adaptation to complex dynamic environments not only means that 
finding the roots of the disease just got a whole lot more complex (as 
it is not restricted to the role of a few genes) but this view also opens 
new routes to stop or even reverse cancer progression 7.  Normal 
organ ecosystems (and the tissues that define them) maintain a 
dynamic balance or homeostasis  between their cellular and environmental components and therefore 
do not create selection pressures that lead to adaptation. 
This  homeostasis is a defining feature of normal healthy body organs (such as those in which cancer 
has not been initiated). Evolution selects for organisms that achieve homeostasis and this 
evolutionary process also makes them capable of recovering from environmental and genetic 
perturbations 8,9. The normal form and function of most tissues (defined by the integration of multiple 
cellular, extracellular, chemical and physical signals/constraints) is  to maintain a homeostatic balance 
and carry out the role they are required to perform. Homeostasis  loss is  traditionally seen as  a key 
initial step on the route to cancer development 10,11. At its  simplest tissue homeostasis is the balance 
between cell proliferation and apoptosis  such that the tissue architecture and function remains 
constant. It is no accident that disruptions in these processes are considered as key features of 
oncogenic transformation. Fortunately, there are multiple mechanisms that regulate these processes 
and actively ensure homeostatic maintenance, mainly through the regulation of both proliferation and 
apoptosis. These mechanisms fall into the two broad camps of cellular (e. g. cell-cell adhesion, cell-
ECM adhesion), and environmental (e.g. metabolic factors, growth factors, stroma) although there is 
a great deal of feedback between these camps with changes in one driving the other. Therefore to 
escape homeostatic control mutant cells  need to significantly modify their baseline phenotypes and 
ignore environmental signals. This will be profoundly influenced by both cellular (in terms of 
phenotypic traits such as cell adhesion) and environmental heterogeneity (in terms of metabolite 
levels and stromal communication) and the feedback between them. 
Cellular heterogeneity represents an intrinsic variability that may be driven by genetic or non-
genetic factors  but importantly provides the means for driving homeostatic disruption and responding 
to it. This  heterogeneity further emphasises the need to understand interactions that occur within the 
cancer ecosystem i.e. between cells  and between cells and their environment. Genetic heterogeneity 
within a tumour is  often referred to as  intratumour heterogeneity and is currently of great interest to 
the cancer community as it has highlighted a potential issue with molecular signatures and even 
personalised medicine as it is currently understood. Specifically, Swanton and colleagues12 have 
shown that multiple biopsies from the same tumour display distinct genetic profiles and yet are 
Figure 1. Parasitism: Parasitic  wasp 
cocoons attached to a caterpillar. By 
Jacob Scott, M.D.
phenotypically similar. This 
genotypic divergence and 
phenotypic convergence 
has also been observed 
across many d i f fe rent 
cancers, including those 
originating in the lung, 
Kidney 12, prostate and 
brain  13,14. We believe that 
this disparity, between 
genotype and phenotype, is 
a natural result of the organ 
ecosystems that these 
c a n c e r o r i g i n a t e i n , 
regardless of the specific 
mutations that may facilitate 
the cancers progression the 
intricate dialogue between 
the tumour cells and their 
environment selects for 
c l o n e s t h a t a r e b e s t 
adapted phenotypically to 
survive. 
From our discussion above 
it is  clear to us that tumours 
a r e m a d e o f a 
heterogeneous mixture of 
ce l ls and that tumour 
h e t e r o g e n e i t y, w h i c h 
manifests i tself at the 
genotypic and phenotypic 
level, affects the way that 
tumour cells  interact with 
other tumour cells, other 
healthy cells  as well as the 
physical microenvironment. 
F u r t h e r m o r e , t h e s e 
interactions can drive the 
behaviour of healthy cells 
such as fibroblasts, which 
c a n b e p e r m a n e n t l y 
transformed into carcinoma 
assoc ia ted f ib rob las ts 
(CAFs)40 under the right 
conditions. An ecosystem 
view of cancer dictates that 
cancer progression is a complex process that emerges from the interactions between individuals and 
their environment.  How can we hope to understand tissue homeostasis and evolution-driven 
disruption that leads to cancer? Purely experimental approaches are unpractical given the complexity 
Box 1: The Hawk-Dove game
Imagine a species in which individuals could have either aggressive  or 
meek strategies to resolve disputes over food. Let's call the former hawks 
and the latter doves. When two doves have to share food (which we will 
refer as V) they just divide it in two halves (each getting V/2). When two 
hawks dispute over food they fight and the victor takes the spoils (V) 
whereas the loser is assumed to be severely harmed (-C). In the third 
scenario, when a hawk and a dove meet, the dove balks away from the 
fight leaving all the food to the hawk. This  information is captured in the 
payoff table shown below. EGT can tell us a few things about this 
population. For instance, the obvious one: that a population made of dove-
like individuals is susceptible to be invaded by a few hawks. Intriguingly we 
can also learn that in many cases  a population made of hawks is unlikely to 
be immune to invasion by a handful of doves: assuming that hawks fight 
until one of them is severely beaten then a dove that doesn't fight might go 
hungry before it meets another dove but that still beats being severely 
injured. With a little information about how serious the average injury would 
be and how much a given resource would help reproduction we could 
guess what the proportion of aggressive versus meek individuals would be 
in the long term. This is what, in game theoretical parlance, is  known as an 
evolutionary stable set of strategies, 
which implies that the ecosystem is 
at an equilibrium that will not be 
easily disrupted. A population in this 
type of equilibrium will recover from 
perturbations, even if part of the 
populat ion changes st rategy 
(unless, of course, we consider 
alternative phenotypic strategies to 
hawk and dove). Similar games can be played with tumour cell populations. 
A good example would be a tumour with tumour phenotypes that move 
away when confronted with scarce resources (motile) and tumour 
phenotypes that stay to use them (proliferative). This scenario was studied 
using a Hawk-Dove game15. In our view, a multicellular organism can be 
seen as a group of cells  in a dynamic equilibrium (known as homeostasis) 
that is robust and stable for phenotypic strategies that are normal in a 
healthy organism but not necessarily to cancerous ones.This phenotypic 
approach to study cancer can be quite useful. It is widely accepted that 
tumour cells acquire a number of new phenotypical capabilities on the path 
towards malignancy10 . The interactions among different tumour phenotypes 
can be studied using EGT to investigate the possible sequence of steps 
that characterise cancer progression as well as the circumstances that lead 
to the emergence of increasingly aggressive phenotypes.
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of interactions and time scales involved in cancer. Fortunately there already exists mathematical and 
computational tools that can be used to study ecosystems regardless of size, scale, and complexity. 
2. Mathematical tools
One good example of a mathematical tool to study evolution in ecosystems is  game theory (GT). GT 
was initially introduced to understand human and sociological behaviour. With GT we can study 
games in which the outcome affecting a player depends, not only on the strategy used, but on the 
strategies employed by the other players. A key aspect is that a  game strategy is not good or bad 
considered in isolation. Only when compared with the strategies employed by other players can we 
make that call. John Maynard Smith pioneered the use of this tool to study evolutionary dynamics  in 
biology. This is known as evolutionary game theory (EGT). The GT assumption that players have to 
be rational is, paradoxically, better suited to the individuals in sociology, economics  or war. The force 
of natural selection keeps ecosystem denizens focused on optimising the bottom line: long term 
reproduction. In the games studied by evolutionary game theoreticians, individuals  compete for 
available resources using a variety of strategies. These features and behaviours, known as the 
phenotypic strategy, determine the winners and losers of evolution. We, and others, have developed 
simple mathematical models  using EGT to understand homeostasis and its disruption in cancer (for 
an example of an evolutionary game take a look at box 1). Many lessons can be learned from very 
simple games like that one.
1.  One crucial lesson, especially when used to understand cancer evolution, is  that focusing on 
indiscriminately destroying as many cancer cells as possible is not necessarily the best thing to do 
for a patient. In EGT, the long term (equilibrium) outcome of a game depends on the interactions 
between the players, not on the size of the population.  A treatment based exclusively on 
indiscriminately removing most (but not all) cancer cells may have only a temporary effect as in 
most cases the original number of tumour cells will eventually be restored and exceeded. Many 
EGT models  show that a more effective alternative would be based on changing the way cells 
interact with each other and their environment which would affect their fitness and thus, potentially, 
drive tumour evolution towards less aggressive cell types or at least to a stable coexistence that 
would be less harmful to the patient 7.  
2. Intra tumour heterogeneity is  a crucial property of cancer, and the dynamics of a tumour can 
change dramatically if more phenotypes with different traits emerge in a population of cancer cells. 
A good example of this can be seen in 15,16, a variation of the game explained in box 1. In this 
version of the game we consider the two phenotypes of the original game: invasive (INV) and 
proliferative (AG), and add a new one: glycolytic (GLY). The resulting table can be seen in the 
payoff table above this paragraph. In the original situation with two phenotypes, the presence of 
more aggressive motile phenotypes depended almost exclusively on the cost of motility (cost:an 
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Table 1 needs to be read following the columns. For instance, fitness payoff for an AG cell
interacting with another AG, E(AG, AG), is 1/2 because AG cells have to share available
resources. Wh n an AG cell meets an INV cell then the INV cell will l ave for another location,
obtaining the base payoff minus the cost of motility 1 – c, whereas the AG cell gets access to all
the available resources and thus the base payoff in full. When an AG cell meets a GLY cell, they
both have to share the available resources. Furthermore, the AG cell loses fitness due to acidi-
fication of the environment. GLY cells never get the full base payoff because their metabolism
is less efficient.
 
RESULTS
 
We have adopted a standard EGT analysis to study equilibria between the different phenotypes
in two scenarios: (1) mutation(s) leading to invasive cells capable of motility in a tumour com-
posed of autonomous growth cells (AG, INV) and (2) a tumour containing autonomous growth,
motile and glycolytic cells (AG, INV, GLY).
 
Scenario 1: AG and INV
 
This scenario studies the situation in which a mutation can confer motility/invasiveness on
tumour cells that already are capable of autonomous growth, that is, the tumour is populated by
AG cells, which can acquire the INV phenotype.
A population of AG cells is immune to invasion from a mutant INV phenotype if the fitness
of two AG cells interacting together is greater than that of the mutant INV cell’s interaction with
an AG cell. Alternatively, if the fitness of an AG cell playing with a second one is the same as
that of an INV cell playing an AG cell, then the AG cell might still be immune to invasion if
the payoff of an AG cell playing an INV cell is greater than that of an INV cell playing another
INV cell. The payoff table shows that as long as motility represents a non-negligible cost, then
the only thing required of a population of AG cells to be immune to invasion by an INV phenotype
is that the fitness payoff of two AG cells is greater than or equal to the fitness payoff for an INV
Table 1. Payoff table that represents the change in fitness of a tumour cell with a given phenotype interacting with
another cell 
AG INV GLY
AG 1– c
INV 1 1 – k
GLY 1 – c
The three phenotypes in the game are autonomous growth (AG), invasive (INV) and glycolytic (GLY). The base payoff 
in a given interaction is equal to 1 and the cost of moving to another location with respect to the base payoff is c. The 
fitness cost of acidity is n and k is the fitness cost of having a less efficient glycolytic metabolism. The table should be 
read following the columns, and thus the fitness change for an invasive cell interacting with an autonomous growth 
would be 1 – c.
1
2
1
2
    + −n k
1
2
  −
c
1
2
  − n
1
2
  − k
abstraction for the fitness that moving cells pay in terms of degrading the extra cellular matrix and 
avoiding anoikis). The addition of a new phenotype alters the game by changing the incentives in 
favour of motile phenotypes. By making proliferative phenotypes less successful, glycolytic 
phenotypes increase the relative fitness advantage of motile phenotypes resulting in more 
aggressive tumours than in the original situation. In general EGT can be used to explore how 
changes in tumour’s phenotypic heterogeneity could change the evolutionary dynamics in a cancer 
even if, as in the example, that intermediate phenotype might not be evolutionarily successful in the 
long term.
3. Modern clinical cancer research is betting that personalised treatments and targeted therapies are 
our best shot at providing durable cures  to many types of cancer. Understanding the impact of 
targeted treatments in cancer is  easier with tools like EGT where the effects of selective therapies 
in heterogeneous tumours  can be studied. Using a model described in the above table 17 we have 
explored how treatments could affect tumour heterogeneity and clonal dominance. An example 
from this game can be seen in figure 2 showing a tumour with two main clonal populations (D, I), 
and a stromal population (S) that has been co-
opted to help the more successful tumour 
population (D, in this  scenario). In this case, 
treatment designed to impact the maximum 
possible number of tumour cells has left behind 
a smaller tumour population and its growth 
potential unaffected. Furthermore, the resulting 
tumour, which ini t ia l ly was incredibly 
susceptible, is  now completely resistant to the 
treatment.
We will produce better treatments  if we use 
evolution in our favour instead of ignoring it as 
the driving force of tumour progression. An 
ecologically enlightened approach would take 
into account what we learned before: that 
killing the most tumour cells might not be the 
best strategy,  that intra-tumour heterogeneity 
increases the chances  of tumour recurrence 
after treatment and that treatments represent a form of selection - where phenotypes  that are not 
selected against will survive and lead to not only recurrent cancer but resistant cancer. An approach 
where tumour diversity could be reduced in stages, and treatments chosen so they select for 
increasingly more benign or easier to treat tumours. An example of such an approach was initially 
proposed by Merlo and colleagues 1 who dubbed it sucker’s gambit. The idea of sucker’s gambit is 
reactive oxygen species (Kundu and Surh, 2008; Schetter et al,
2010).
Fibroblasts and osteoclasts are also known to change in
response to the presence of a tumour. In a series of papers in
the 1980s, Schor and co-workers demonstrated that fibroblasts
adjacent to carcinoma epithelium were fundamentally different
from normal stroma and that these changes were implicated
in neoplastic progression (Schor et al, 1987). These malignancy-
associated changes occurred only in a subset of the resident
fibroblasts (Schor and Schor, 1987; Schor et al, 1988). Specific
references to tumour-associated or carcinoma-associated fibro-
blasts, myofibroblasts and reactive stroma have become abundant
in literature from the 1970s onwards.
The relationship between osteoclasts and tumour cells in
metastatic disease in the bone has been of recent interest, and
much research has gone into understanding signalling cascades
including many of the matrix metalloproteinases (Lynch et al,
2005), which seem to promote a vicious cycle of bone turnover and
tumour promotion. Sadly, although these pathways are reasonably
well understood, the clinical application of our knowledge in this
realm has had little impact with the notable exception of
cladronate in breast cancer – a case where a stromal-directed
therapy, not an anticancer agent, has actually been shown to
increase survival (Diel et al, 2008).
We, and others, have shown that carcinoma-associated fibro-
blasts derived from human prostate tumours can promote
tumourigenesis (Olumi et al, 1999; Barclay et al, 2005; Franco
et al, 2011; Kiskowski et al, 2011). We have also demonstrated that
the stromal phenotype in a tumour can be used as a basis for
patient disease-progress prognostication (Ayala et al, 2003;
Yanagisawa et al, 2007). Although some of the pathways under-
lying the ability of cancer stroma to regulate tumourigenesis have
been elucidated (Ao et al, 2006, 2007; He et al, 2007), the situation
is complex and many interactions remain to be explored (Bierie
and Moses, 2006), especially with regard to the progression of the
carcinoma towards either stromagenic (Figure 1 left) or stromal-
independent outcomes (Figure 1 right).
In this paper we introduce an Evolutionary Game The ry (EGT)
model that studies the evolution of three different cell populations
over time: stromal cells, a dependant tumour phenotype capable of
co-opting stromal cells to support its growth, and an independent
tumour phenotype that does not require microenvironmental
support, be it stromal associated or not. This model is then applied
to the clinical problem of metastatic prostate cancer.
THE GAME
In EGT, the behaviour of the players is not assumed to be based on
rational payoff maximisation, but it is shaped by trial and error
adaptation through natural selection (Smith, 1982). In EGT, a
strategy is not a deliberate course of action but a phenotypic trait.
The payoff is fitness in the Darwinian sense: more average
reproductive success. In this context, interactions between the
players are important, be it in a cooperative or competitive
manner, as they determine whether it will become a larger share of
the population (Sigmund and Nowak, 1999). Fitness is also
population dependant, so a given subpopulation might become
more (or less) fit if the numbers of a different subpopulation with
whom it interacts go up (or down).
Genetic and epigenetic changes can transform the cells in a
healthy tissue. One change is to produce individualistic tumour
cells that compete for space and resources (Nowell, 1976; Crespi
and Summers, 2005; Merlo et al, 2006) and which can attract
support from other cell types, for example, by replicating
developmental scenarios where cell growth is a normal outcome.
Under the view of tumours as ecosystems, it is possible to use tools
from ecology, such as EGT, to study the evolution of the different
cellular populations. EGT has been used to explore various aspects
of cancer (Tomlinson and Bodmer, 1997), including glioma
progression (Basanta et al, 2008, 2011), the influence of the
tumour–host interface in colorectal carcinogenesis (Gatenby and
Vincent, 2003), the role of phenotypic variability in multiple
myeloma (Dingli et al, 2009), and the evolution of a number of
phenotypic traits such as motility and invasion (Mansury et al,
2006; Bellomo et al, 2008) or microenvironmental independence
(Anderson et al, 2009).
As in our previous work (Anderson et al, 2009), the model
assumes a tumour with two different epithelial phenotypes:
tumour cells that depend on the microenvironment for survival
(D) and those that are independent of the microenvironment (I).
Table 1 shows the payoffs for each cell type when interacting with
others. A further assumption is that no other phenotypes are
relevant in the context of the game and that spatial considera-
tions will not affect the outcome (Hofbauer and Sigmund, 1998).
Figure 1 Lethal prostate cancer phenotypes. On the left we show a glandular tumour with abundant reactive stroma (stromogenic carcinoma). The image
on the right is a poorly differentiated cancer without intervening reactive stroma (stroma-independent tumour).
Table 1 Payoff table that represents the interactions between the three
cell types considered in the model
S D I
S 0 a 0
D 1+a–b 1!2b 1!b+r
I 1!g 1!g 1!g
The fitness of each of the phenotypes (S, Stroma; D, microenvironmentally
dependent; I,microenvironmentally independent) depends on the interactions with
other phenotypes and the values of the costs and benefits resulting from these
interactions. These costs and benefits are: a (benefit derived from the cooperation
between a S cell and a D cell), g (cost of being microenvironmentally independent),
b (cost of extracting resources from the microenvironment and r (benefit derived by
D from paracrine growth factors produced by I cells.
Prostate cancer tumour and stroma interactions
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Figure 2. Result from a replicator equation resulting from a 
game where certain stromal cells (S) and certain tumour cells 
(D) cooperate. Treatment (sky blue) kills stromal cells 
effectively selecting for the I tumour population.
that we could change the selection pressure in an evolving 
tumour such that the easier to treat phenotypes would be 
selected for. Subsequently, Gatenby, Brown and Vincent 
suggested using insights gained in ecology to further 
explore the idea of the “sucker’s  gambit”. With an 
evolutionary double bind, the species whose numbers need 
to be controlled must be predated by at least two different 
types of predators 18,19. The secret of a successful 
evolutionary double bind is that the strategies of the two 
predator species have to be synergistic such that a prey 
evolving in order to be attacked by one of the predators will 
in fact become more susceptible to being attacked by the 
other. This type of strategy is easy to conceive as a EGT 
model and recently we have framed clinical results from 
Antonia and colleagues 20,21 in an evolutionary double bind to try to explain their results. In their 
research, Antonia and colleagues show that when applying two different therapies to lung cancer 
patients, a p53 vaccine and standard chemotherapy, the order of the application of treatments has a 
substantial impact on the efficacy of the overall treatment. Specifically, patients that went through 
chemotherapy before the p53 vaccine was administered responded much better than patients where 
only one treatment was used or those where the sequence was reversed. The EGT model considered 
three populations: those susceptible to all treatments, those resistant to chemotherapy and those 
resistant to the p53 vaccine 22. The model highlights  the importance of finding the right sequence of 
treatments such that evolution can be directed to tumours that are easier to treat.
Interactions and cooperation
Another potential use of the cancer-
ecosystem viewpoint is the study of the 
evolutionary dynamics leading to the 
emergence of cooperation 2,23,24. A 
common misunderstanding about 
evolution is that the survival of the fittest 
means that only the strongest and 
meanest survive and that they have 
done so through competition only. But 
nature is abundant with examples of inter 
and intra species  cooperation. The trick 
is  that cooperation can only emerge 
within the constraints  of selection: it can 
only be sustainable if everybody, or at 
l e a s t t h e g e n e s t h a t p r o m o t e 
cooperat ion, benef i ts f rom the i r 
interactions.
Interactions between individuals 
(people, animals, cells, bacteria) are 
normally categorised as mutualistic 
(figure 3), competitive, predatory, 
parasitic (figure 1) and comensalistic 
(see box 2)25. EGT is particularly useful 
at studying the interactions between the 
Box 2: Competition and Cooperation
Mutualistic interactions are those in which both 
interacting parties benefit equally. Competitive 
interactions are those in which both parties have a 
detrimental effect on each other. Predatory and parasitic 
interactions are similar in that one of the parties benefits 
from the interactions whereas the other suffers, but in 
the former the harmed party will significantly reduce its 
fitness and in the latter the fitness reduction is much 
smaller. Finally comensalism describes interactions in 
which one of the 
par t i es de r i ves 
neither harm nor 
gain whereas the 
other obtains some 
( o f t e n s m a l l ) 
benefit. This table 
shows the costs (-) 
and benefits (+) of 
i n t e r a c t i o n s 
b e t w e e n t w o 
parties (A and B). All these interactions may occur, to 
some degree or the other, in a tumour ecosystem. For 
instance tumour cells compete for space and nutrients 
but, intriguingly they may also team up to produce 
enough growth factors to sustain tumour growth23.
Figure 3. Symbiosis. Both the bee and the 
flower derive a benefit from their interaction. 
Wellcome Library, London
players, how those affect tumour Darwinian evolution, and how evolution might lead to or away from 
homeostasis. However there are other important aspects in an ecosystem that can be approached in 
more detail with the help of other mathematical tools. 
Most EGT models do not explicitly capture the role of space in an ecosystem, thus assuming that 
players interact with each other with a frequency that is only dependent on the relative proportion of 
each subpopulation. EGT models are also usually concerned with the relative proportion of the 
different subpopulations but, given the limitations of the approach, rarely do they study the absolute 
numbers in the population. Absolute numbers could be inferred from a properly parameterised model 
if the initial subpopulations are known as the fitness payoffs  represent long-term proliferation rates. As 
it has already been reported before, many EGT models use more abstract parameters so that 
meaningful extrapolations between fitness and population size are not possible.
These limitations are not as severe as they might seem: many as  of yet unaddressed questions  can 
be answered by relatively more abstract approaches such as EGT. Its simplicity and focus on 
interactions makes it easy to understand the role of different subpopulations  in a heterogeneous 
tumour. Alternatively, modelling tools in ecology can also use parameters derived from observations 
in the field. In cancer research there is  abundant data resulting from in vivo and in vitro  experiments 
at both the molecular and cellular levels  that could be integrated with the right mathematical tool. One 
good example of such an approach is individual based models where each cell in a tumour is given 
its own identity and where the properties  of the tumour as a whole can naturally emerge from the 
interactions between the different cells and between the cells and their environment. Individual 
based models (IBM) are a large class of models that consider both space and time explicitly and 
offer and ideal methodology to integrate some features  of the other approaches discussed here. One 
of the pioneering IBM approaches  is  cellular automata (CA), which as in the case of GT where first 
introduced by Von Neumann, and were first used to explore biological questions 26. Theoretical 
ecologists have utilised CA to investigate population dynamics 27,28 and the role of space in the 
interactions between individuals 29. Specifically they can 
incorporate detailed descriptions of the individual (tumour cell, fish, 
fox etc) defining its  behaviour (migrate, reproduce, die etc) in a 
given context (Savannah, lake, muscle tissue etc).  IBMs therefore 
capture the spatial and temporal variation that characterises real 
ecosystems allowing us to explore the robustness of key 
homeostatic mechanisms 8,9.  Moreover, they have been 
extensively used by the modelling community to look at many 
different biological systems focussing on how individuals  and their 
interactions collectively drive different evolutionary outcomes.
An IBM approach that has been used extensively in cancer 
modelling are Hybrid models that integrate both continuous and 
discrete variables and are able to incorporate biological 
phenomena on various temporal and spatial scales (See 30 for a 
recent review). These models represent cells  as individual discrete 
entities and often use continuous concentration or density fields to 
model cell intracellular and extracellular environments. By their 
very nature, hybrid models are ideal for examining direct 
interactions between individual cells and between the cells and 
their microenvironment, but they also allow us to analyse the 
emergent properties of complex multicellular systems (such as 
cancer). It is worth noting that as  these interactions take place on 
the intracellular and intercellular levels, but are manifested by 
Figure 4. Example of simulation in 
which an IBM is used to explore how 
the interactions between tumour cells 
a n d t h e i r e n v i r o n m e n t a f f e c t 
progression.The screen on the top left 
shows tumour (red) and stromal (black 
and brown) interacting. Other screens 
show concentrations of elements of 
the physical  microenvironment (TGFβ, 
Matrix Degrading Enzymes and Extra 
Cellular Matrix). An IBM model can 
shed light on the spatial  distribution of 
relevant cellular species.
changes on the tissue level, the emergent behaviour of growing multiclonal tumours are almost 
impossible to infer intuitively. Hybrid models can facilitate our understanding of the underlying 
biophysical processes  in tumour growth. For example, by using high-throughput simulation 
techniques, we can examine the impact that changes in specific cell interactions (or their 
microenvironment) have on tumour growth and treatment. Hybrid models are often multiscale by 
definition integrating processes on different temporal and spatial scales, such as gene expression, 
intracellular pathways, intercellular signalling, cell growth, or migration. We have developed many 
hybrid models to investigate different aspects  of cancer. For example, the Hybrid Discrete-continuum 
Cellular Automaton (HDC) model has  been used to study how the interactions between tumour cells 
and stromal cells  via a molecule known 
as TGFβ to explain prostate cancer 
progression. Figure 4 shows an 
example of the simulations produced by 
the model. With this approach it is 
possible to parameterise each cell 
independently using data collected from 
in vivo and in vitro experiments. 
Importantly, the mathematical model 
integrates all these biological data in a 
way that can yield clinically relevant 
insights by studying the emergent 
properties of the prostate cancer 
through timescales that typically cover 
decades.
Another major advantage of Hybrid 
models  is their abil i ty to easily 
incorporate heterogeneity both in terms 
of the tumour cell phenotype and the 
tumour microenvironment. Since 
interactions between tumours and their 
microenvironment drive selection and 
ultimately define the ecology of the 
t i ssue i n wh ich the tumour i s 
developing, these models represent ideal tools to investigate evolution and selection in a growing 
tumour. Anderson and colleagues at Moffitt and Vanderbilt have shown (see figure 5) that different 
microenvironments (in terms of Extra Cellular Matrix density or nutrient concentration) will produce 
tumours with distinct morphological characteristics 6,31,32. The research also shows that harsher 
microenvironments will select for more aggressive phenotypes  (those that would lead to a worse 
prognosis for the patient) whereas nicer microenvironments  could yield more heterogeneous tumours 
(where less aggressive clones coexist with more aggressive ones). These types of insights would be 
difficult to produce with only experimental and clinical data. Further research by the same group lead 
to a carefully parameterised version of the HDC model 33. Using measurements  of different cancer 
cell lines typically used in research labs across  the world, the new model allowed them to study the 
effect of seeding in vitro different combinations of phenotypes in a number of micro-environments and 
made the surprising prediction that aggressive tumour cells have evolved to become essentially 
microenvironmentally independent (producing their own niche as required). 
An extra strength of IBMs is  that they can be combined with other mathematical tools like networks 
and EGT in order to complement each other’s strength. As an example of the latter, Basanta and 
colleagues explored the emergence of motility in a tumour made of, essentially, proliferative cells 
Figure 5. Simulation results from the HDC model  under three different 
microenvironments: (A) uniform ECM, (B) Grainy ECM and (C) Low 
nutrient. The Upper row shows the resulting tumor cell distributions 
obtained after 3 months of simulated growth, we can see that the three 
different microenvironments have produced distinct tumour 
morphologies. The lower row shows the relative abundance of a 
possible 100 tumour phenotypes over time as the tumour invaded each 
of the different microenvironments. We note that there are 
approximately 6 dominant phenotypes in the uniform tumour, 2 in the 
grainy and 3 in the low nutrient tumour. These phenotypes have several 
traits in common: low cell-cell adhesion, short proliferation age, and 
high migration coefficients. In each tumour, one of the phenotypes is the 
most aggressive and also the most abundant, particularly in B and C. All 
parameters used in the simulations are identical  with the exception of 
the different microenvironments.
using both EGT (see Box 1) and a CA-based IBM 34. While the EGT implementation focused on the 
analysis of role of the cell-cell interactions in the evolutionary timescale (steady state), the CA 
provided insights on the role of space. Networks and IBM can also be combined, as shown by Gerlee 
and colleagues 35, so as  to bridge the scales between the cellular level (the IBM) and the pathway 
level (the network). This allows for a model in which the behaviour of a cell is controlled by pathways 
(network nodes or vertices) and their interactions (network edges) as well as by the interactions with 
nearby cells and their microenvironment (CA lattice site). 
3. Discussion 
Traditionally the ecological perspective is  firmly grounded at the scale of the phenotype and 
essentially ignores anything below this scale. It tends to be more encompassing at that scale and 
embraces all the different players of the ecosystem. In contrast with this  perspective, the cancer 
biology view is  very much centred on the genetic and molecular scales  for which there is a wealth of 
data. Whilst this provides a solid foundation to work from for cancer ecologists, this data is 
unbalanced due to the poorly quantified phenotypic-scale. This imbalance is the result of the 
dominance and success of reductionism in cancer research. Reductionism is undoubtedly 
responsible for the exquisite level of understanding of many of the genes and pathways that are 
involved in tumour initiation and progression in a variety of organs. Both of these approaches have 
limitations but also have their own strengths that in fact compliment one another. Ideally we want to 
unify this biological-gene-centric view with the ecological-phenotype-centric view, however, 
experimentally this is difficult if not impossible, without the aid of theoretical approaches like the ones 
discussed above. In fact, there already exists  IBMs that explicitly try to bridge the genotypic and 
phenotypic scales by incorporating elements of EGT and network theory 36,37.
The ecosystem view is, ultimately, a holistic one that sees cancer progression as  a process that 
emerges from the interactions between multiple cellular species and interactions with the tumour 
microenvironment.  An ecosystem perspective presents us with intriguing implications. One is that 
cancer is an evolutionary driven escape from homeostasis. It also casts aspects of cancer 
progression under a different light: are metastatic cells the ones that represent the best and most 
adapted cells at the primary site? Or, on the contrary, does  metastasis and invasion represent the 
only alternative for less successful phenotypes, capable of escaping the primary site but unable to 
compete with better adapted ones locally?  Could it be only a by-product of tumour cells  acquiring the 
abilities to move and detach from the main body of the tumour? Is it the result of cooperation or 
competition? Regardless of the answer to these questions, an ecological interpretation of cancer 
would predict that metastasis will occur at sites in which the tumour cells  will have a better chance of 
survival and colonisation. This will depend not only on the distance from the primary site or on the 
availability of lymphatic or blood vessels for physical connectivity 38 but also on the suitability of the 
new site for colonisation. Metastatic cells are already likely to be reasonably adapted to specific 
environmental conditions. A secondary site that somewhat resembles key features  of the primary one 
while providing the metastatic cells  with nutrients and room for growth will always be a more likely 
target for a secondary tumour.
One might ask, what would a cancer ecosystem look like? Unsurprisingly it will contain tumour cells, 
epithelial cells, nutrients  and growth factors. Less intuitively it will also include immune and 
endothelial cells, nerves, different stromal phenotypes as well as epithelial cells  in carcinomas. Figure 
6 shows one example of an ecosystem for bone metastasis, though a simplification it already gives 
information in a purely visual way about the different types of interactions that are occurring. By 
adding weights to the interactions we can use the theoretical tools discussed above to investigate 
how a new tumour disrupts homeostasis (initiation), develops  (growth), responds to perturbations 
( t reatment), evolves over t ime 
(progression) and how it may best be 
controlled or destroyed. The key point 
is  that the ecosystem perspective 
places the emphasis on interactions 
and their consequences. A better 
understanding of these interactions 
could be used to hinder and even 
p o t e n t i a l l y r e v e r s e t u m o u r 
progression. Tissue homeostasis 
disruption due to alterations in the 
tissue ecosystem could, potentially, be 
reversed via renormalisation of the 
tumour microenvironment 39. For 
instance, it is known that normal 
stromal cells can inhibit progression 
towards mal ignancy in certa in 
carcinomas 40. Regaining homeostasis might not mean tumour eradication but instead may represent 
a new state where we live with cancer more like a chronic disease, kept in check by a combination of 
drugs that change in response to changes in the tumour or its microenvironment. 
The timing for an ecosystemic view of cancer could not be better: with the development of high 
throughput automated microscopy the ability to gather substantial amounts of cellular information is 
becoming a reality. With this new information the cancer ecosystem is becoming more complete and 
therefore theoretical oncologists will have a better understanding of the key phenotypic strategies  and 
mechanisms of interaction that tumour cells, and other relevant cells employ. Clearly this means we 
are more likely to be successful at producing models that are both holistic (taking into account the 
multiple scales at which cancer takes  place) and quantitative (in which model parameters and 
predictions can be compared with experiments) i.e. qolistic approaches 41. 
The heart of the matter is  that an ecological view of tumours does not invalidate but complements 
and builds upon decades of cancer research and undoubtedly this will lead to a better understanding 
of the biology of cancer and to new and improved therapies. If we may use the old analogy but 
framed slightly differently: we need to properly understand the trees (e.g. every leaf, twig and branch) 
before we can understand the forest but we cannot afford to ignore the forest because the trees  are 
so interesting on their own.
Figure 6. Outline of the ecosystem in a prostate to bone metastasis with 
several types of cancer cells interacting with other cellular populations like 
osteoblasts, osteoclasts, osteocytes and stem cells. Tumour cells interact 
to compete and cooperate for resources like nutrients, space and growth 
factors.
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